Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 19.56.
Forward PE Ratio (19.56) = Close Price ($119.57) / Consensus Forward EPS ($6.11)
FORWARD PE RATIO
19.56
SECTOR MEDIAN · HEALTHCARE
20.29
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-3.57%
vs the sector median at left
Encompass Health Corporation
Market Cap
$11.86B
Forward PE Ratio
19.56
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Encompass Health Corporation (EHC) | $11.86B | 19.56 |
| DaVita Inc. (DVA)vs › | $11.48B | 12.13 |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 14.09 |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 37.68 |
| Tempus AI, Inc. (TEM)vs › | $12.38B | N/A |
| Globus Medical, Inc. (GMED)vs › | $11.13B | 16.57 |
| Penumbra, Inc. (PEN)vs › | $12.64B | 68.18 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.50B | 40.31 |
| Universal Health Services, Inc. (UHS)vs › | $10.45B | 7.65 |
| Molina Healthcare, Inc. (MOH)vs › | $10.37B | N/A |
Trailing P/E
19.5
reported TTM EPS
Forward P/E
19.6
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $6.11 implies -0.5% EPS decline vs the reported trailing $6.14.
At today's $119.57 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $6.11 | $5.88 – $6.22 | 8 | 19.6x |
| 2027-12-31 | $6.68 | $6.23 – $6.97 | 8 | 17.9x |
| 2028-12-31 | $7.27 | $6.61 – $7.57 | 4 | 16.4x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
